Skip to content
Attorneys

Todd B. Buck, Ph.D.

Headshot of Todd Buck dressed professionally
Virginia
703-291-1444

About

Dr. Todd B. Buck brings over two decades of experience as a life sciences attorney, leveraging a rare combination of scientific knowledge and legal expertise to guide companies across the pharmaceutical, biotechnology, and medical device industries. Holding a Ph.D. in Pharmacology and Toxicology, Todd offers deep insights into intellectual property strategies, FDA regulatory compliance, and high-value transactions. His clientele ranges from startups to multi-billion-dollar corporations, for whom he manages patent portfolios, advises on mergers and acquisitions, and negotiates licensing agreements.

Todd’s career is marked by his ability to seamlessly blend scientific understanding with legal strategy, making him an invaluable advisor in complex areas such as gene and cell therapies. His representation of Nobel Laureates, success in patent interference cases, and strong record in regulatory disputes demonstrate his capacity to navigate intricate legal challenges with precision. Known for his creative problem-solving and hands-on approach, Todd consistently delivers strategic solutions that drive innovation and business growth.

Practice Areas

Intellectual Property Law, Life Sciences, Healthcare Law, Biotechnology, FDA, Transactions and Licensing, Corporate Governance

Education

  • J.D., The George Washington School of Law, 2003
  • Ph.D. University of Georgia, Pharmacology and Toxicology, 1999
  • B.S. Oglethorpe University, Biology, (Chemistry and Mathematics minors), 1992

Admitted Jurisdictions

  • Virginia
  • District of Columbia
  • United States Patent and Trademark Office (USPTO)
  • Court of Appeals for the Federal Circuit Bar

Associations

  • American Intellectual Property Law Association

Industry Expertise

  • Life Sciences and Healthcare

Career Highlights

  • Counsel to Nobel Laureates: Represented Nobel Laureates as lead counsel in a patent interference case involving pioneering RNAi technology.
  • High-Impact IP Strategy: Developed and managed comprehensive patent portfolios for life sciences companies, including work that significantly increased the value of a client’s Initial Public Offering (IPO) and eventual acquisition.
  • Trial Success: Achieved summary judgment dismissal of a trade secret misappropriation complaint in New Jersey, serving as first chair trial counsel.
  • Successful Appeal: Overturned an adverse USPTO judgment as first chair trial counsel in a § 145 appeal, reopening prosecution on a key patent in a client’s portfolio.
  • In-House Expertise: Served as de facto Chief IP Counsel and General Counsel for several startups, advising on patent strategies, regulatory compliance, and overall product lifecycle management.